Truist Securities Maintains Buy on Eli Lilly, Raises Price Target to $1370

Benzinga Newsdesk www.benzinga.com Positive 89.3%

Neg 0% Neu 0% Pos 89.3%

Truist Securities analyst Robyn Karnauskas maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1281 to $1370.